Yuan Hu

650 total citations
23 papers, 505 citations indexed

About

Yuan Hu is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Yuan Hu has authored 23 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Yuan Hu's work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (4 papers) and Hearing, Cochlea, Tinnitus, Genetics (3 papers). Yuan Hu is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (4 papers) and Hearing, Cochlea, Tinnitus, Genetics (3 papers). Yuan Hu collaborates with scholars based in China, United States and Sweden. Yuan Hu's co-authors include Su‐Hua Sha, Kayla Hill, Shiming Yang, John J. Lemasters, Jun Chen, Xianren Wang, Yibang Chen, Xian‐Zhe Dong, Ping Liu and Dai‐Hong Guo and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Antioxidants and Redox Signaling.

In The Last Decade

Yuan Hu

22 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuan Hu China 10 267 158 103 71 58 23 505
Jingping Fan China 14 276 1.0× 66 0.4× 65 0.6× 40 0.6× 31 0.5× 27 505
Qinglian He China 13 460 1.7× 73 0.5× 356 3.5× 79 1.1× 39 0.7× 32 707
Dongming Hou China 6 221 0.8× 36 0.2× 57 0.6× 58 0.8× 43 0.7× 10 424
Wan‐Chen Huang Taiwan 16 472 1.8× 89 0.6× 165 1.6× 99 1.4× 17 0.3× 37 773
Meenu Madan United States 12 305 1.1× 76 0.5× 42 0.4× 22 0.3× 12 0.2× 16 496
Xingang Lu China 14 353 1.3× 12 0.1× 113 1.1× 71 1.0× 30 0.5× 27 587
P. M. Nishina United States 6 265 1.0× 26 0.2× 44 0.4× 57 0.8× 9 0.2× 8 566
Yi Luan China 9 172 0.6× 124 0.8× 58 0.6× 68 1.0× 15 0.3× 19 409
Hiroki Kittaka Japan 7 101 0.4× 112 0.7× 29 0.3× 26 0.4× 14 0.2× 12 374
Xiaoyu Lu China 16 356 1.3× 46 0.3× 198 1.9× 31 0.4× 42 0.7× 44 595

Countries citing papers authored by Yuan Hu

Since Specialization
Citations

This map shows the geographic impact of Yuan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan Hu more than expected).

Fields of papers citing papers by Yuan Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan Hu. The network helps show where Yuan Hu may publish in the future.

Co-authorship network of co-authors of Yuan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan Hu. A scholar is included among the top collaborators of Yuan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan Hu. Yuan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Yuan, et al.. (2025). Comparison of saliva and blood derived cell free RNAs for detecting oral squamous cell carcinoma. Scientific Reports. 15(1). 4645–4645. 2 indexed citations
3.
Liu, Yichen, Qingyan Sun, Jingwen Guo, et al.. (2025). Dual ferroptosis induction in N2-TANs and TNBC cells via FTH1 targeting: A therapeutic strategy for triple-negative breast cancer. PubMed Central. 6(1). 101915–101915. 6 indexed citations
4.
Liu, Qiong, et al.. (2020). ACP-5862 suppresses esophageal squamous cell carcinoma growth through inducing apoptosis via activation of endoplasmic reticulum stress and ROS production. Biochemical and Biophysical Research Communications. 534. 995–1002. 7 indexed citations
5.
Dong, Xian‐Zhe, et al.. (2019). LncRNA COL1A1-014 is involved in the progression of gastric cancer via regulating CXCL12-CXCR4 axis. Gastric Cancer. 23(2). 260–272. 32 indexed citations
6.
Tavassoly, Iman, Yuan Hu, Shan Zhao, et al.. (2019). Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses. Molecular Oncology. 13(8). 1725–1743. 24 indexed citations
7.
Hu, Yuan, Weiwei Guo, Zhaohui Hou, et al.. (2019). Establishment of a Large Animal Model for Eustachian Tube Functional Study in Miniature Pigs. The Anatomical Record. 302(6). 1024–1038. 6 indexed citations
8.
Guan, Jing, Dayong Wang, Wenjian Cao, et al.. (2016). SIX2 haploinsufficiency causes conductive hearing loss with ptosis in humans. Journal of Human Genetics. 61(11). 917–922. 11 indexed citations
9.
Li, Muhan, Jing Zhang, Xian‐Zhe Dong, et al.. (2016). Effect of six class of Kaixin San formulas on pharmacological and preliminary mechanism of Alzheimer's disease mice. China Journal of Chinese Materia Medica. 41(7). 1269–1274. 2 indexed citations
10.
Hu, Yuan, Xianren Wang, Kayla Hill, et al.. (2015). Autophagy Attenuates Noise-Induced Hearing Loss by Reducing Oxidative Stress. Antioxidants and Redox Signaling. 22(15). 1308–1324. 142 indexed citations
11.
Mu, Li-Hua, et al.. (2015). One new cycloartane triterpene glycoside fromBeesia calthaefolia. Natural Product Research. 30(3). 316–321. 8 indexed citations
12.
Hu, Yuan, et al.. (2014). Inhibition of the JAK/STAT pathway with ruxolitinib overcomes cisplatin resistance in non-small-cell lung cancer NSCLC. APOPTOSIS. 19(11). 1627–1636. 80 indexed citations
13.
Zhou, Yang, Qi Yao, Ying‐Xia Cui, et al.. (2013). Clinical and cytogenetic characterization of a boy with a de novo pure partial trisomy 16q24.1q24.3 and complex chromosome rearrangement. American Journal of Medical Genetics Part A. 161(4). 897–900. 2 indexed citations
15.
Hu, Yuan, Weiqiang Lü, Liyan Wang, et al.. (2012). Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1). European Journal of Medicinal Chemistry. 62. 148–157. 30 indexed citations
16.
Hu, Yuan. (2011). EVALUATION OF STABILIZING EXERCISE OF THE LUMBAR SPINE IN THE TREATMENT OF CHRONIC NON-SPECIFIC LOW BACK PAIN. 2 indexed citations
17.
Angeli, Simón I., Xiao Mei Ouyang, Wen Liu, et al.. (2008). Audiological and genetic features of themtDNA mutations. Acta Oto-Laryngologica. 128(7). 732–738. 27 indexed citations
18.
Wang, Qiuju, Qingzhong Li, Dongyi Han, et al.. (2005). Clinical and molecular analysis of a four-generation Chinese family with aminoglycoside-induced and nonsyndromic hearing loss associated with the mitochondrial 12S rRNA C1494T mutation. Biochemical and Biophysical Research Communications. 340(2). 583–588. 44 indexed citations
19.
Hu, Yuan, et al.. (1999). [Screening for mitochondrial 1555(G) mutation in patients with aminoglycoside antibiotic-induced deafness].. PubMed. 16(3). 141–4. 4 indexed citations
20.
Hu, Yuan, et al.. (1998). [Screening for the 1555G mutation in mitochondrial DNA in pedigrees with aminoglycoside antibiotic induced deafness].. PubMed. 33(2). 67–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026